Daxor Revenue 2010-2011 | DXR
Daxor revenue from 2010 to 2011. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Daxor Annual Revenue (Millions of US $) |
|
|---|---|
| 2011 | $1 |
| 2010 | $2 |
| 2009 | $2 |
| Daxor Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.045B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.429B | 10.54 |
| Quest Diagnostics (DGX) | United States | $15.377B | 15.89 |
| DaVita (DVA) | United States | $12.061B | 14.98 |
| Encompass Health (EHC) | United States | $8.712B | 22.30 |
| Chemed (CHE) | United States | $8.709B | 26.99 |
| Elanco Animal Health (ELAN) | United States | $8.401B | 21.80 |
| Option Care Health (OPCH) | United States | $5.235B | 19.82 |
| RadNet (RDNT) | United States | $4.083B | 85.00 |
| Amedisys (AMED) | United States | $3.121B | 22.11 |
| LifeStance Health (LFST) | United States | $2.622B | 0.00 |
| Astrana Health (ASTH) | United States | $2.179B | 29.46 |
| Addus HomeCare (ADUS) | United States | $1.789B | 25.59 |
| U.S Physical Therapy (USPH) | United States | $1.603B | 42.90 |
| Pennant (PNTG) | United States | $0.680B | 35.94 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.481B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.316B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |